Multiple Assemblies exist for SMTL entry 4w9j
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (ligand 13); X-RAY DIFFRACTION 2.20 Å

	SMTL ID 4w9j.1 Ligands N-acetyl-L-leucyl-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9j.2 Ligands N-acetyl-L-leucyl-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9j.3 Ligands N-acetyl-L-leucyl-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer
	SMTL ID 4w9j.4 Ligands N-acetyl-L-leucyl-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide Polypeptides Transcription elongation factor B polypeptide 2; Transcription elongation factor B polypeptide 1; Von Hippel-Lindau disease tumor suppressor Oligo-state hetero-1-1-1-mer